4.5 Review

Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: current status and future perspectives

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate

Sarita Garg et al.

Summary: This study evaluated the effects of the vitamin E analog gamma-tocotrienol (GT3) on GI recovery in nonhuman primates (NHPs) after total-body irradiation. The results showed that GT3 promoted the survival and proliferation of intestinal stem cells, reduced cell apoptosis, and had a radioprotective function. Therefore, GT3 has the potential to be used as a prophylactic medical countermeasure for radiation-induced GI injury.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Multidisciplinary Sciences

Gamma-tocotrienol, a radiation countermeasure, reverses proteomic changes in serum following total-body gamma irradiation in mice

Elliot Rosen et al.

Summary: The study found that prophylactic administration of gamma-tocotrienol (GT3) provided 100% protection in a mouse model of total-body irradiation. Protein analysis identified specific serum proteins associated with radiation injury and protection.

SCIENTIFIC REPORTS (2022)

Article Biochemistry & Molecular Biology

Gamma-Tocotrienol Modulates Total-Body Irradiation-Induced Hematopoietic Injury in a Nonhuman Primate Model

Tarun K. Garg et al.

Summary: Radiation exposure causes acute damage to hematopoietic and immune cells. A study on nonhuman primates has shown that GT3 can accelerate hematopoietic recovery and aid in the recovery of circulating neutrophils and platelets, suggesting its potential as a medical countermeasure for radiation-induced injury to the hematopoietic system.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Medicine, Research & Experimental

Lung transcriptome of nonhuman primates exposed to total- and partial-body irradiation

Neetha Nanoth Vellichirammal et al.

Summary: The study investigated the impact of a supralethal dose of radiation on alterations in the lung transcriptome using a nonhuman primate model. Significant radiation-induced changes in the lung transcriptome were observed for both total-body irradiation (TBI) and partial-body irradiation (PBI), with common signaling pathways being upregulated in both exposures.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Biotechnology & Applied Microbiology

Sargramostim in acute radiation syndrome

Hillard M. Lazarus et al.

Summary: This article introduces the treatment of acute high-dose ionizing radiation caused by radiologic accidents, including the approved therapy sargramostim, which effectively accelerates marrow recovery and increases survival. Studies suggest that sargramostim is safer than hematopoietic cell transplants and requires fewer resources in large-scale exposure events, such as those caused by tactical nuclear weapons or nuclear terrorism.

EXPERT OPINION ON BIOLOGICAL THERAPY (2022)

Article Pharmacology & Pharmacy

An update on romiplostim for treatment of acute radiation syndrome

Vijay K. Singh et al.

Summary: This article introduces the emergency situation when a nuclear accident or terrorist attack occurs in populated areas, focusing on the treatment of acute radiation syndrome. It specifically discusses the latest FDA-approved drug, romiplostim, as a treatment modality.

DRUGS OF TODAY (2022)

Review Pharmacology & Pharmacy

Entolimod as a radiation countermeasure for acute radiation

Vijay K. Singh et al.

Summary: Entolimod has been shown effective in protecting against and mitigating acute radiation syndrome in rodents and nonhuman primates. It reduces radiation-induced apoptosis and accelerates tissue regeneration. Clinical evaluation of its pharmacokinetics, toxicity, and biomarkers, as well as FDA approval for investigational new drug, fast-track, and orphan drug statuses, have paved the way for its progression in pre-emergency use authorization.

DRUG DISCOVERY TODAY (2021)

Article Biology

Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model

Yifei Zhong et al.

Summary: The study found that starting sargramostim treatment at 48 hours post high dose ionizing radiation exposure improved survival, while delaying treatment up to 120 hours post exposure also had beneficial hematological effects, reducing mortality rates in the animals.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2021)

Review Pharmacology & Pharmacy

Repurposing Pharmaceuticals Previously Approved by Regulatory Agencies to Medically Counter Injuries Arising Either Early or Late Following Radiation Exposure

Vijay K. Singh et al.

Summary: With the increasing risks of radiological or nuclear attacks, there is a renewed interest in developing radiation medical countermeasures. In order to expedite drug approval, drug developers are turning to repurposing agents for which safety and clinical data are already available. This strategy allows for faster and more cost-effective approval compared to developing entirely new agents.

FRONTIERS IN PHARMACOLOGY (2021)

Review Pathology

Metabolomics-based predictive biomarkers of radiation injury and countermeasure efficacy: current status and future perspectives

Vijay K. Singh et al.

Summary: Metabolomics is highly informative in assessing radiation exposure levels and identifying biomarkers of radiation injury and countermeasure efficacy. Recent advances in analytics have led to targeted and untargeted approaches for biomarker identification. Biomarkers are essential for assessing radiation exposure levels and determining scaling factors for radiation countermeasures.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2021)

Review Biology

Radiation countermeasures for hematopoietic acute radiation syndrome: growth factors, cytokines and beyond

Vijay K. Singh et al.

Summary: This article reports on the status of pharmaceuticals in late stage development for treating acute injuries caused by radiological/nuclear exposures. Four medications have been deemed safe and effective by the US FDA for hematopoietic acute radiation syndrome (H-ARS), primarily recombinant growth factors. Additional medications are needed for other sub-syndromes of ARS, potentially through a polypharmaceutical or bioengineered approach.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2021)

Review Pharmacology & Pharmacy

Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems

Vijay K. Singh et al.

EXPERT OPINION ON PHARMACOTHERAPY (2020)

Article Biochemistry & Molecular Biology

A Metabolomic and Lipidomic Serum Signature from Nonhuman Primates Administered with a Promising Radiation Countermeasure, Gamma-Tocotrienol

Amrita K. Cheema et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Medicine, General & Internal

Are We Prepared for Nuclear Terrorism?

Robert P. Gale et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Editorial Material Pathology

Biomarkers for acute radiation syndrome: challenges for developing radiation countermeasures following animal rule

Vijay K. Singh et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)

Article Biochemistry & Molecular Biology

Plasma Derived Exosomal Biomarkers of Exposure to Ionizing Radiation in Nonhuman Primates

Amrita K. Cheema et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Pharmacology & Pharmacy

An update on sargramostim for treatment of acute radiation syndrome

V. K. Singh et al.

DRUGS OF TODAY (2018)

Article Biochemistry & Molecular Biology

Development of Orally Administered γ-Tocotrienol (GT3) Nanoemulsion for Radioprotection

Grace A. Ledet et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Cell Biology

Evolutionarily conserved serum microRNAs predict radiation-induced fatality in nonhuman primates

Wojciech Fendler et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Review Pathology

Use of biomarkers for assessing radiation injury and efficacy of countermeasures

Vijay K. Singh et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)

Article Environmental Sciences

PROGENITOR CELL MOBILIZATION BY GAMMA-TOCOTRIENOL: A PROMISING RADIATION COUNTERMEASURE

Vijay K. Singh et al.

HEALTH PHYSICS (2016)

Article Chemistry, Multidisciplinary

The Vitamin E Analog Gamma-Tocotrienol (GT3) Suppresses Radiation-Induced Cytogenetic Damage

Rupak Pathak et al.

PHARMACEUTICAL RESEARCH (2016)

Article Biology

Radioprotective Efficacy of Gamma-Tocotrienol in Nonhuman Primates

Vijay K. Singh et al.

RADIATION RESEARCH (2016)

Article Biology

Gamma-Tocotrienol Modulates Radiation-Induced MicroRNA Expression in Mouse Spleen

Sanchita P. Ghosh et al.

RADIATION RESEARCH (2016)

Article Medicine, Legal

GRAS determination scientific procedures and possible alternatives

Gary M. Williams et al.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)

Review Biochemistry & Molecular Biology

γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status

Vijay K. Singh et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Article Biology

Pegfilgrastim Improves Survival of Lethally Irradiated Nonhuman Primates

Kim G. Hankey et al.

RADIATION RESEARCH (2015)

Article Pharmacology & Pharmacy

FILGRASTIM FOR THE TREATMENT OF HEMATOPOIETIC ACUTE RADIATION SYNDROME

A. M. Farese et al.

DRUGS OF TODAY (2015)

Review Chemistry, Medicinal

Radiation countermeasure agents: an update (2011-2014)

Vijay K. Singh et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2014)

Article Multidisciplinary Sciences

Progenitors Mobilized by Gamma-Tocotrienol as an Effective Radiation Countermeasure

Vijay K. Singh et al.

PLOS ONE (2014)

Review Biology

Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures

Vijay K. Singh et al.

JOURNAL OF RADIATION RESEARCH (2013)

Article Biology

Filgrastim Improves Survival in Lethally Irradiated Nonhuman Primates

Ann M. Farese et al.

RADIATION RESEARCH (2013)

Review Multidisciplinary Sciences

Progenitor Cells as a Bridging Therapy for Radiation Casualties

Vijay K. Singh et al.

DEFENCE SCIENCE JOURNAL (2011)

Article Hematology

Preclinical development of a bridging therapy for radiation casualties

Vijay K. Singh et al.

EXPERIMENTAL HEMATOLOGY (2010)

Article Biology

Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector

Sanchita P. Ghosh et al.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2009)

Review Oncology

Multitargeted therapy of cancer by tocotrienols

Kalanithi Nesaretnam

CANCER LETTERS (2008)

Article Biochemistry & Molecular Biology

Design, synthesis, and antioxidant potency of novel α-tocopherol analogues in isolated membranes and intact cells

Paola Palozza et al.

FREE RADICAL BIOLOGY AND MEDICINE (2008)

Article Environmental Sciences

ESTIMATION OF HEALTH HAZARDS RESULTING FROM A RADIOLOGICAL TERRORIST ATTACK IN A CITY

K. G. Andersson et al.

RADIATION PROTECTION DOSIMETRY (2008)